113 related articles for article (PubMed ID: 30927073)
1. Impact of 9q deletions on the classification of patients with acute myeloid leukemia.
Balk B; Haferlach T; Meggendorfer M; Kern W; Haferlach C; Stengel A
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2871-2874. PubMed ID: 30927073
[No Abstract] [Full Text] [Related]
2. Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.
Herold T; Metzeler KH; Vosberg S; Hartmann L; Jurinovic V; Opatz S; Konstandin NP; Schneider S; Zellmeier E; Ksienzyk B; Graf A; Krebs S; Blum H; Cristina Sauerland M; Büchner T; Berdel WE; Wörmann BJ; Mansmann U; Hiddemann W; Bohlander SK; Spiekermann K; Greif PA
Genes Chromosomes Cancer; 2017 Jan; 56(1):75-86. PubMed ID: 27636548
[TBL] [Abstract][Full Text] [Related]
3. Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted region.
Naarmann-de Vries IS; Sackmann Y; Klein F; Ostareck-Lederer A; Ostareck DH; Jost E; Ehninger G; Brümmendorf TH; Marx G; Röllig C; Thiede C; Crysandt M
Leuk Res; 2019 Jan; 76():15-23. PubMed ID: 30476680
[TBL] [Abstract][Full Text] [Related]
4. Concomitant presence of trisomy 21 and del(9q) in acute myeloid leukemia.
Kwong YL; Chan LC
Cancer Genet Cytogenet; 1992 Nov; 64(1):92-4. PubMed ID: 1458456
[TBL] [Abstract][Full Text] [Related]
5. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
[TBL] [Abstract][Full Text] [Related]
6. Cytological features of 9q- deletions in AML.
Hoyle C; Sherrington PD; Hayhoe FG
Br J Haematol; 1987 Jun; 66(2):277-8. PubMed ID: 3475113
[No Abstract] [Full Text] [Related]
7. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
Leuk Lymphoma; 2008 Mar; 49(3):508-16. PubMed ID: 18297528
[TBL] [Abstract][Full Text] [Related]
9. A case of M2 acute myeloblastic leukemia associated with an interstitial 9q deletion.
Lin CC; De Braekeleer M; Etches WS; Thay TY
Cancer Genet Cytogenet; 1987 Jan; 24(1):177-80. PubMed ID: 3466670
[TBL] [Abstract][Full Text] [Related]
10. Deletion 9q as the sole karyotypic abnormality in myelocytic disorders: a new case of myelodysplastic syndrome and its prognostic implications in acute myelocytic leukemia.
Wan TS; Ma ES; Lam CC; Chan LC; Lee KK; Au WY
Cancer Genet Cytogenet; 2003 Sep; 145(2):184-6. PubMed ID: 12935935
[No Abstract] [Full Text] [Related]
11. Interstitial 9q- deletion in a case of acute myeloid leukemia-M2 arising from a granulocytic sarcoma.
Lunde JH; Allen EF
Cancer Genet Cytogenet; 1994 Dec; 78(2):239-41. PubMed ID: 7828160
[TBL] [Abstract][Full Text] [Related]
12. Interstitial 9q deletion is associated with CD7+ acute leukemia of myeloid and T lymphoid lineage.
Ferrara F; Scognamiglio M; Di Noto R; Schiavone EM; Poggi V; Fiorillo A; Libertini R; Vicari L; Del Vecchio L; Sebastio L
Leukemia; 1996 Dec; 10(12):1990-2. PubMed ID: 8946942
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia with del(X)(p21) and cryptic RUNX1/RUNX1T1 from ins(8;21)(q22;q22q22) revealed by atypical FISH signals.
Jang JH; Yoo EH; Kim HJ; Kim DH; Jung CW; Kim SH
Ann Clin Lab Sci; 2010; 40(1):80-4. PubMed ID: 20124335
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations.
Fröhling S; Schlenk RF; Krauter J; Thiede C; Ehninger G; Haase D; Harder L; Kreitmeier S; Scholl C; Caligiuri MA; Bloomfield CD; Döhner H; Döhner K
Genes Chromosomes Cancer; 2005 Apr; 42(4):427-32. PubMed ID: 15645492
[TBL] [Abstract][Full Text] [Related]
15. Coexistent t(8;21)(q22;q22) Translocation and 5q Deletion in Acute Myeloid Leukemia.
Yamamoto K; Yakushijin K; Sanada Y; Kawamoto S; Matsuoka H; Minami H
J Clin Exp Hematop; 2015; 55(3):181-5. PubMed ID: 26763368
[TBL] [Abstract][Full Text] [Related]
16. Secondary acute myelogenous leukemia (AML) with trisomy 10 and del(9q) following precursor B-cell acute lymphoblastic leukemia (ALL) with a hyperdiploid karyotype.
Al-Tahou K; Jamil S; Mody R; Knaus A; Micale M; Huang J
Cancer Genet; 2012 Oct; 205(10):533-6. PubMed ID: 22944559
[TBL] [Abstract][Full Text] [Related]
17. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.
Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196
[TBL] [Abstract][Full Text] [Related]
18. Genomic Features of Interstitial Deletions of Chromosome 9q in Acute Myeloid Leukemia.
Qi Z; Wen KW; Ki A; Prakash S; Kogan S; Yu J
Cytogenet Genome Res; 2022; 162(3):119-123. PubMed ID: 35675801
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.
Eisfeld AK; Kohlschmidt J; Schwind S; Nicolet D; Blachly JS; Orwick S; Shah C; Bainazar M; Kroll KW; Walker CJ; Carroll AJ; Powell BL; Stone RM; Kolitz JE; Baer MR; de la Chapelle A; Mrózek K; Byrd JC; Bloomfield CD
Leukemia; 2017 Jun; 31(6):1278-1285. PubMed ID: 27843138
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China.
Cheng Y; Wang Y; Wang H; Chen Z; Lou J; Xu H; Wang H; Qian W; Meng H; Lin M; Jin J
Leukemia; 2009 Oct; 23(10):1801-6. PubMed ID: 19474801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
